1. Lax SJ, Van Vogt E, Candy B, et al. Topical anti‐inflammatory treatments for eczema: network meta‐analysis. Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD015064. DOI: 10.1002/14651858.CD015064.pub2.
2. Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol. 2021 Jan;126(1):21-31. doi: 10.1016/j.anai.2020.08.016.
3. Goh MS, Yun JS, Su JC. Management of atopic dermatitis: a narrative review. Medical Journal of Australia. 2022 Jun 15;216(11).
4. Butala S, Paller AS. Optimizing topical management of atopic dermatitis. Annals of Allergy, Asthma & Immunology. 2022 May 1;128(5):488-504.
5. Harvey J, Lax SJ, Lowe A, Santer M, Lawton S, Langan SM, Roberts A, Stuart B, Williams HC, Thomas KS. The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review. Skin Health and Disease. 2023 Oct;3(5):e268.
6. Umar BU, Rahman S, Dutta S, Islam T, Nusrat N, Chowdhury K, Ahmad WF, Haque M. Management of atopic dermatitis: the role of tacrolimus. Cureus. 2022 Aug;14(8).
7. Nakashima C, Shigeto Y, Atsushi O. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergology International, 2022. 71.1 (2022): 40-46.
8. Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. Journal of Allergy and Clinical Immunology, 2021. 148.4 (2021): 927-940.
9. AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024 Mar;132(3):274-312
Facebook 
Masuk dengan Email
